These results suggest that MRI radiomics combined with deep learning analysis shows potential for clinical practice in the assessment of PD-L1 expression in HCC, which may achieve the stratification of HCC patients for immunotherapy. The gene discussed is CD274; the disease is hepatocellular carcinoma.